The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature
<i>Background and Objectives:</i> In the era of the coronavirus disease 2019 (COVID-19) pandemic, the management of immunosuppressive (IS) therapy in kidney transplant (KT) recipients affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires attention. It is not y...
Main Authors: | Roberta Angelico, Francesca Blasi, Tommaso Maria Manzia, Luca Toti, Giuseppe Tisone, Roberto Cacciola |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/57/5/435 |
Similar Items
-
Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample
by: Hasan Irtiza, et al.
Published: (2021-03-01) -
Investigating an Emerging Virus During a Sudden Pandemic Outbreak
by: Ronit Sarid
Published: (2020-07-01) -
Understanding the unusual viral outbreak: Coronavirus disease 2019
by: Tarun Kumar Suvvari, et al.
Published: (2020-01-01) -
Different clinical presentations of two renal transplant recipients with coronavirus disease 2019: a case report
by: Jing Li, et al.
Published: (2020-09-01) -
Heart-Kidney Transplanted patient affected by COVID-19 pneumonia treated with tocilizumab on top of immunosuppressive maintenance therapy
by: Enrico Ammirati, et al.
Published: (2020-08-01)